Lhasa Limited shared knowledge shared progress

Toxicity Publications

The following links provide access to relevant Toxicity publications for the last 2 years. If you would like to view older publications, or to refine your search criteria further please search the library.

TitlePublishedTypeProducts
Important considerations for the validation of QSAR models for in vitro mutagenicityNovember 2018Derek NexusSarah NexusVitic Nexus
Zeneth: an in silico tool to aid identification of degradantsOctober 2018pdf fileZeneth
Webinar - A defined approach for predicting skin sensitisation hazard and potency.October 2018
In Silico Predictions For GenotoxicityOctober 2018pdf fileDerek NexusSarah Nexus
Meeting report, ICH M7 relevant workshop: use of (Q)SAR systems and expert judgmentSeptember 2018pdf fileDerek NexusSarah Nexus
Development Of A Network Of Adverse Outcome Pathways (AOPs) For CarcinogenicitySeptember 2018Vitic NexusDerek NexusSarah Nexus
A pharma-wide approach to address the genotoxicity prediction of primary aromatic amines.June 2018
Toxicity Studies for Degradation Impurities - An Industry PerspectiveJune 2018pdf fileDerek NexusSarah Nexus
Sarah Nexus Strain InformationMarch 2018pdf fileSarah Nexus
Vitic: Lhasa’s Toxicity Information Management SystemMarch 2018pdf fileVitic Nexus
An Overview of Recent Skin Sensitisation Work at LhasaMarch 2018pdf fileDerek Nexus
Using New Features to Further Interrogate Sarah Nexus PredictionsMarch 2018pdf fileSarah Nexus
Strain profiles: Moving beyond binary Ames classificationMarch 2018pdf fileSarah Nexus
In Silico Prediction of DILI - Extraction of Histopathology Data from Preclinical Toxicity Data Studies of the eTOX Database for new In SIlico Models of HepatotoxicityMarch 2018pdf fileETOX
Derek Nexus BrochureJanuary 2018pdf fileDerek Nexus
Skin Sensitsation BrochureJanuary 2018pdf fileDerek NexusVitic Nexus
Derek Nexus Carcinogenicity QMRF.pdfDecember 2017pdf fileDerek Nexus
Derek Nexus Chromosome Damage QMRF.pdfDecember 2017pdf fileDerek Nexus
Derek Nexus Mutagenicity QMRF.pdfDecember 2017pdf fileDerek Nexus
Derek Nexus Skin Sensitisation QMRF.pdfDecember 2017pdf fileDerek Nexus
Derek Nexus HERG QMRF.pdfDecember 2017pdf fileDerek Nexus
Derek Nexus Teratogenicity QMRF.pdfDecember 2017pdf fileDerek Nexus
Drug Master File (DMF) Holders Preferred PGI Control Strategy Under ICH M7 in Support of Abbreviated New Drug Applications (ANDAs)November 2017pdf file
Profilling potential drug-induced hepatotoxicity thorugh modelling molecular initiating events (MIEs)November 2017pdf file
Understanding Negative Predictions in Derek Nexus - A Detailed WorkflowNovember 2017pdf fileDerek Nexus
Understanding Negative Predictions in Derek NexusNovember 2017pdf fileDerek Nexus
An Overview of Lhasa Limited Collaborative Data Sharing InitiativesOctober 2017pdf fileDerek NexusETOXExcipientsIntermediatesVitic Nexus
Carbamates and ICH M7 classification: Making use of expert knowledgeApril 2017Derek NexusSarah Nexus
A quantitative in silico model for predicting skin sensitization using a nearest neighbours approach within expert-derived structure–activity alert spacesMarch 2017Derek Nexus
Developmental and Reproductive Toxicity Predictions in Derek NexusMarch 2017pdf fileDerek Nexus
Computational Systems Pharmacology and Toxicology - Tools for Green Molecular Design to Reduce Toxicological RiskMarch 2017Derek NexusSarah Nexus
Redox cycling versus general liver toxicity: Read-across case study with phenolsFebruary 2017pdf file
Prediction of microvesicular liver steatosis: Read-across case study with VPA analoguesFebruary 2017pdf file
(Q)SAR tools for priority setting: A case study with printed paper and board food contact material substancesFebruary 2017Derek NexusSarah Nexus
Setaria 1.0 Installation GuideDecember 2016pdf fileSetaria
Setaria 1.0 Release NotesDecember 2016pdf fileSetaria

© 2018 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.

IP: 54.167.18.170 | Group: ###groupid###